Baidu
map

Scientific Reports:日发现一种蛋白质或能推迟渐冻症发展

2012-08-15 蓝建中 新华社

日本岐阜药科大学教授原英彰率领的研究小组在8月13日的英国《科学报告》(Scientific Reports)杂志网络版上报告说,他们发现了一种能推迟渐冻症发展的蛋白质。这一发现有望为弄清该病的发病机制和开发新的治疗药物作出贡献。 肌萎缩侧索硬化症俗称渐冻症,这种疾病的患者运动神经出现障碍,导致全身肌肉逐渐变得无力。渐冻症患者约有10%属于遗传性患病。由于不清楚详细的致病原因,医学界一直未找到根

日本岐阜药科大学教授原英彰率领的研究小组在8月13日的英国《科学报告》(Scientific Reports)杂志网络版上报告说,他们发现了一种能推迟渐冻症发展的蛋白质。这一发现有望为弄清该病的发病机制和开发新的治疗药物作出贡献。

肌萎缩侧索硬化症俗称渐冻症,这种疾病的患者运动神经出现障碍,导致全身肌肉逐渐变得无力。渐冻症患者约有10%属于遗传性患病。由于不清楚详细的致病原因,医学界一直未找到根治此病的方法。

研究小组在对渐冻症实验鼠和正常实验鼠进行比较时,发现渐冻症实验鼠体内的“膜贯通糖蛋nmb”(GPNMB)与病情的发展有很大关系。

研究人员通过基因操作,使十几只渐冻症实验鼠体内的GPNMB得以大量表达,结果发现与对照组的渐冻症实验鼠相比,前者的发病时间推迟,生存时间也延长了1至2周左右,换算成人类,相当于生命延长了10个月左右,从而证实GPNMB能够推迟渐冻症发展。

名古屋大学研究生院、新潟大学等机构的研究人员也参与了此项研究。

doi:10.1038/srep00530
PMC:

PMID:

The Bcl-2 family member BIM has multiple glaucoma-relevant functions in DBA/2J mice

Jeffrey M. Harder; Kimberly A. Fernandes; Richard T. Libby

Axonal insult induces retinal ganglion cell (RGC) death through a BAX-dependent process. The pro-apoptotic Bcl-2 family member BIM is known to induce BAX activation. BIM expression increased in RGCs after axonal injury and its induction was dependent on JUN. Partial and complete Bim deficiency delayed RGC death after mechanical optic nerve injury. However, in a mouse model of glaucoma, DBA/2J mice, Bim deficiency did not prevent RGC death in eyes with severe optic nerve degeneration. In a subset of DBA/2J mice, Bim deficiency altered disease progression resulting in less severe nerve damage. Bim deficient mice exhibited altered optic nerve head morphology and significantly lessened intraocular pressure elevation. Thus, a decrease in axonal degeneration in Bim deficient DBA/2J mice may not be caused by a direct role of Bim in RGCs. These data suggest that BIM has multiple roles in glaucoma pathophysiology, potentially affecting susceptibility to glaucoma through several mechanisms.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1765486, encodeId=4fcc1e6548686, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 12 13:02:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269684, encodeId=a616126968458, content=<a href='/topic/show?id=5e106628237' target=_blank style='color:#2F92EE;'>#渐冻症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66282, encryptionId=5e106628237, topicName=渐冻症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri Aug 17 06:02:00 CST 2012, time=2012-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296863, encodeId=a2ff1296863fa, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Aug 17 06:02:00 CST 2012, time=2012-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374666, encodeId=bf6413e466617, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Fri Aug 17 06:02:00 CST 2012, time=2012-08-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1765486, encodeId=4fcc1e6548686, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 12 13:02:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269684, encodeId=a616126968458, content=<a href='/topic/show?id=5e106628237' target=_blank style='color:#2F92EE;'>#渐冻症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66282, encryptionId=5e106628237, topicName=渐冻症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri Aug 17 06:02:00 CST 2012, time=2012-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296863, encodeId=a2ff1296863fa, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Aug 17 06:02:00 CST 2012, time=2012-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374666, encodeId=bf6413e466617, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Fri Aug 17 06:02:00 CST 2012, time=2012-08-17, status=1, ipAttribution=)]
    2012-08-17 xjy02
  3. [GetPortalCommentsPageByObjectIdResponse(id=1765486, encodeId=4fcc1e6548686, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 12 13:02:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269684, encodeId=a616126968458, content=<a href='/topic/show?id=5e106628237' target=_blank style='color:#2F92EE;'>#渐冻症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66282, encryptionId=5e106628237, topicName=渐冻症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri Aug 17 06:02:00 CST 2012, time=2012-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296863, encodeId=a2ff1296863fa, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Aug 17 06:02:00 CST 2012, time=2012-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374666, encodeId=bf6413e466617, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Fri Aug 17 06:02:00 CST 2012, time=2012-08-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1765486, encodeId=4fcc1e6548686, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 12 13:02:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269684, encodeId=a616126968458, content=<a href='/topic/show?id=5e106628237' target=_blank style='color:#2F92EE;'>#渐冻症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66282, encryptionId=5e106628237, topicName=渐冻症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri Aug 17 06:02:00 CST 2012, time=2012-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296863, encodeId=a2ff1296863fa, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Aug 17 06:02:00 CST 2012, time=2012-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374666, encodeId=bf6413e466617, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Fri Aug 17 06:02:00 CST 2012, time=2012-08-17, status=1, ipAttribution=)]
    2012-08-17 jichang

相关资讯

Chemistry & Biology:新方法让药物更易进入细胞

制药科学家所面临的最艰巨的挑战之一就是不受药物影响的蛋白质,约80%的蛋白质涉及人类疾病,其中有些蛋白质并不与现有药物发生相互作用,也就是说,这些药物都是无效的。   近日,耶鲁大学研究人员发现了一种新方法可以设计出以前无法进入这些蛋白质的药物。   这项研究发表在7月26日《化学与生物学》杂志上。耶鲁大学化学生物学研究所、论文主要作者Alanna Schepartz博

Nature:先天免疫系统蛋白或成为抵御细菌感染的新靶点

近日,来自St.Jude儿童研究医院的科学家发现了一种新的方法来有效抵御细菌的感染,这种方法通过以先天性的免疫系统组分为靶点,从而激活免疫效应。这项研究中研究者阐述了先天性免疫分子的主要功能是抑制炎症,反过来可以缓冲感染或者其它威胁产生的免疫效应。研究者揭示了蛋白质可以抑制两种途径,这两种途径可以控制特定分子的产生进而与感染进行“斗争”,相关研究成果刊登在了国际著名杂志Nature上。 研究者表

Cell Host & Micro:Chi3l1是一种保护机体免疫系统的关键蛋白

机体中的蛋白质对于维持机体对细菌的免疫反应至关重要,而且部分蛋白质可以保护机体免于自身的免疫效应伤害。近日来自耶鲁大学的研究者研究了一种名为壳多糖酶3(Chi3l1)的一种蛋白质,因为这种蛋白质是存在于植物、昆虫以及人类机体中的一种古老家族的蛋白质。进化上的保守性使得科学家认为Chi3l1在生物机体中扮演着重要的角色。然而目前对于Chi3l1的研究非常之少。 研究小组研究发现,当小鼠缺乏这种蛋白

鹰嘴豆可提取抗肿瘤蛋白质和多肽

        记者近日从中科院新疆理化技术研究所获悉,该所资源化学研究室的科研人员研制出一种从鹰嘴豆豆瓣中提取天然抗肿瘤活性蛋白质和多肽的方法。相关研究成果日前获国家发明专利授权。   目前,肿瘤已成为仅次于心脑血管疾病的第二大杀手,寻找高效、低毒的抗肿瘤药物成为世界范围内相关研究的热点之一。生物活性肽是一类天然存在于动、植物和微生物等生物体内的多功能化合物。动、植物蛋白质经过蛋白酶解以及

J Proteome Res:科学家解决吸烟弱化骨骼之谜

自科学??家们首次发现吸烟为骨质疏松症和骨折的危险因素20年后,今日,一项新的研究阐明了香烟烟雾是如何削弱骨骼的。相关研究论文发表在Journal of Proteome Research研究杂志上,该研究报告得出结论认为香烟烟雾使人们产生促发身体自然存在的破骨行为的一种过量的蛋白质。 Gary Guishan Xiao和他的同事指出,以往的研究表明香烟烟雾中毒素通过影响成骨细胞削弱骨骼,成

Baidu
map
Baidu
map
Baidu
map